Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17039
Country/Region: South Africa
Year: 2016
Main Partner: BroadReach Healthcare
Main Partner Program: South Africa
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $3,890,131 Additional Pipeline Funding: $81,084

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $595,682
Care: TB/HIV (HVTB) $574,598
Care: Pediatric Care and Support (PDCS) $198,561
Strategic Information (HVSI) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $337,122
Treatment: Adult Treatment (HTXS) $1,985,608
Treatment: Pediatric Treatment (PDTX) $198,560
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: 1-9 2017 441
HTS_TST Age/sex: 10-14 Female 2017 177
HTS_TST Age/sex: 10-14 Male 2017 118
HTS_TST Age/sex: 15-19 Female 2017 2,204
HTS_TST Age/sex: 15-19 Male 2017 1,471
HTS_TST Age/sex: 20-24 Female 2017 2,648
HTS_TST Age/sex: 20-24 Male 2017 1,764
HTS_TST Age/sex: 25-49 Female 2017 2,648
HTS_TST Age/sex: 25-49 Male 2017 1,764
HTS_TST Age/sex: 50+ Female 2017 884
HTS_TST Age/sex: 50+ Male 2017 590
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 4,061
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 2,778
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 29,133
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 19,421
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 55,393
HTS_TST Service Delivery Point (Facility): Inpatient 2017 5,220
HTS_TST Service Delivery Point (Facility): Outpatient 2017 47,291
HTS_TST Service Delivery Point (Facility): Pediatric 2017 2,882
HTS_TST Sum of Age/Sex disaggregates 2017 14,268
HTS_TST Sum of Aggregated Age/Sex <15 2017 6,839
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 48,554
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 55,393
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 8
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 6
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 287
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 191
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 345
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 229
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 345
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 230
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 86
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 60
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 44
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 491
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 333
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 3,678
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,454
PMTCT_ART Already on ART at beginning of current pregnancy 2017 232
PMTCT_ART New on ART 2017 154
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 2,073
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 366
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 3
PMTCT_EID Sum of Infant Age disaggregates 2017 366
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 47
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 188
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 280
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 422
PMTCT_STAT By: Known positives at entry 2017 831
PMTCT_STAT By: Number of new positives identified 2017 1,242
PMTCT_STAT Number of new ANC and L&D clients 2017 2,116
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 2,073
PMTCT_STAT Required only for DREAMS countries - By known positives: <15 2017 18
PMTCT_STAT Required only for DREAMS countries - By known positives: 15-19 2017 74
PMTCT_STAT Required only for DREAMS countries - By known positives: 20-24 2017 111
PMTCT_STAT Required only for DREAMS countries - By known positives: 25-49 2017 170
PMTCT_STAT Required only for DREAMS countries - By new positives: <15 2017 29
PMTCT_STAT Required only for DREAMS countries - By new positives: 15-19 2017 111
PMTCT_STAT Required only for DREAMS countries - By new positives: 20-24 2017 168
PMTCT_STAT Required only for DREAMS countries - By new positives: 25-49 2017 256
PMTCT_STAT Sum of Positives Status disaggregates 2017 2,073
PMTCT_STAT_den Required only for DREAMS countries - Denominator: <15 2017 47
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 15-19 2017 191
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 20-24 2017 287
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 25-49 2017 431
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 124
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 698
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 81
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 466
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 1,522
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 1,369
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1,528
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 77
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 154
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1,297
TB_SCREENDX Screen Results: Screened Positive for TB 2017 1,697
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 6,107
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 4,073
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 34,620
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 23,081
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 67,881
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 233
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,319
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 155
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 879
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 2,586
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 2,704
TX_CURR Age/Sex: <1 2017 725
TX_CURR Age/Sex: 1-9 2017 3,629
TX_CURR Age/Sex: 10-14 Female 2017 1,451
TX_CURR Age/Sex: 10-14 Male 2017 1,451
TX_CURR Age/Sex: 15-19 Female 2017 2,177
TX_CURR Age/Sex: 15-19 Male 2017 1,451
TX_CURR Age/Sex: 20-24 Female 2017 4,355
TX_CURR Age/Sex: 20-24 Male 2017 2,902
TX_CURR Age/Sex: 25-49 Female 2017 9,798
TX_CURR Age/Sex: 25-49 Male 2017 6,530
TX_CURR Age/Sex: 50+ Female 2017 1,089
TX_CURR Age/Sex: 50+ Male 2017 727
TX_CURR Aggregated Age/Sex: <15 Female 2017 3,090
TX_CURR Aggregated Age/Sex: <15 Male 2017 2,059
TX_CURR Aggregated Age/Sex: 15+ Female 2017 17,515
TX_CURR Aggregated Age/Sex: 15+ Male 2017 11,676
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 70,625
TX_CURR Sum of Age/Sex disaggregations 2017 3,628
TX_CURR Sum of Aggregated Age/Sex <15 2017 5,149
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 29,191
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 34,340
TX_NEW Aggregated Grouping by Age: <1 2017 60
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 747
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 497
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 4,238
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 2,824
TX_NEW By Age/Sex: 1-9 2017 294
TX_NEW By Age/Sex: 10-14 Female 2017 118
TX_NEW By Age/Sex: 10-14 Male 2017 118
TX_NEW By Age/Sex: 15-19 Female 2017 354
TX_NEW By Age/Sex: 15-19 Male 2017 235
TX_NEW By Age/Sex: 20-24 Female 2017 706
TX_NEW By Age/Sex: 20-24 Male 2017 469
TX_NEW By Age/Sex: 25-49 Female 2017 1,763
TX_NEW By Age/Sex: 25-49 Male 2017 1,176
TX_NEW By Age/Sex: 50+ Female 2017 354
TX_NEW By Age/Sex: 50+ Male 2017 234
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 14,187
TX_NEW Sum of Age/Sex disaggregates 2017 5,527
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 8,306
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 55,334
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 51,113
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 4,598
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 3,067
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 26,072
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 17,376
TX_PVLS Numerator: Indication: Routine 2017 46,003
TX_PVLS Numerator: Indication: Targeted 2017 5,110
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 4,977
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 3,318
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 28,227
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 18,812
TX_PVLS_den Denominator: Indication: Routine 2017 49,798
TX_PVLS_den Denominator: Indication: Targeted 2017 5,536
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 525
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,624
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,050
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,050
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,575
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,050
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,150
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,099
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 7,087
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4,724
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 786
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 525
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,722
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,811
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 15,414
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10,274
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 56,466
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 67,846
TX_RET_den Age/Sex: <1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 693
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,468
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,388
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,388
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,081
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,388
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4,163
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,775
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 9,364
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6,241
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,040
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 693
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,985
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,990
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 16,913
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 11,276
Cross Cutting Budget Categories and Known Amounts Total: $1,025,000
Human Resources for Health $1,025,000